• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

理解协同作用。

Understanding synergy.

出版信息

Am J Physiol Endocrinol Metab. 2013 Feb 1;304(3):E237-53. doi: 10.1152/ajpendo.00308.2012. Epub 2012 Dec 4.

DOI:10.1152/ajpendo.00308.2012
PMID:23211518
Abstract

Analysis of the interactive effects of combinations of hormones or other manipulations with qualitatively similar individual effects is an important topic in basic and clinical endocrinology as well as other branches of basic and clinical research related to integrative physiology. Functional, as opposed to mechanistic, analyses of interactions rely on the concept of synergy, which can be defined qualitatively as a cooperative action or quantitatively as a supra-additive effect according to some metric for the addition of different dose-effect curves. Unfortunately, dose-effect curve addition is far from straightforward; rather, it requires the development of an axiomatic mathematical theory. I review the mathematical soundness, face validity, and utility of the most frequently used approaches to supra-additive synergy. These criteria highlight serious problems in the two most common synergy approaches, response additivity and Loewe additivity, which is the basis of the isobole and related response surface approaches. I conclude that there is no adequate, generally applicable, supra-additive synergy metric appropriate for endocrinology or any other field of basic and clinical integrative physiology. I recommend that these metrics be abandoned in favor of the simpler definition of synergy as a cooperative, i.e., nonantagonistic, effect. This simple definition avoids mathematical difficulties, is easily applicable, meets regulatory requirements for combination therapy development, and suffices to advance phenomenological basic research to mechanistic studies of interactions and clinical combination therapy research.

摘要

分析激素或其他操作与具有定性相似个体效应的组合的相互作用是基础和临床内分泌学以及与整合生理学相关的其他基础和临床研究分支的一个重要课题。功能而非机制分析依赖于协同作用的概念,根据不同剂量-效应曲线相加的某种度量标准,协同作用可以定性地定义为协同作用,也可以定量地定义为超加性效应。不幸的是,剂量-效应曲线的相加远非如此简单;相反,它需要发展一种公理数学理论。我回顾了最常用于超加性协同作用的方法的数学合理性、表面有效性和实用性。这些标准突出了两种最常见的协同作用方法(反应加性和 Loewe 加性)的严重问题,这是等摩尔线和相关响应面方法的基础。我得出的结论是,没有合适的、普遍适用的、用于内分泌学或任何其他基础和临床整合生理学领域的超加性协同作用度量标准。我建议放弃这些度量标准,转而采用协同作用的简单定义,即协同作用(即非拮抗)效应。这种简单的定义避免了数学上的困难,易于应用,符合联合治疗开发的监管要求,并足以将现象学基础研究推进到相互作用的机制研究和临床联合治疗研究。

相似文献

1
Understanding synergy.理解协同作用。
Am J Physiol Endocrinol Metab. 2013 Feb 1;304(3):E237-53. doi: 10.1152/ajpendo.00308.2012. Epub 2012 Dec 4.
2
Synergy: a concept in search of a definition.协同作用:一个寻求定义的概念。
Endocrinology. 2013 Nov;154(11):3974-7. doi: 10.1210/en.2013-1420. Epub 2013 Sep 3.
3
Mathematical formulation of additivity for antimicrobial agents.抗菌剂相加性的数学公式。
Diagn Microbiol Infect Dis. 2006 Aug;55(4):319-25. doi: 10.1016/j.diagmicrobio.2006.01.024. Epub 2006 Apr 19.
4
Interaction index and different methods for determining drug interaction in combination therapy.联合治疗中相互作用指数及确定药物相互作用的不同方法。
J Biopharm Stat. 2007;17(3):461-80. doi: 10.1080/10543400701199593.
5
Parallel dose-response curves in combination experiments.联合实验中的平行剂量反应曲线。
Bull Math Biol. 1998 Mar;60(2):197-213. doi: 10.1006/bulm.1997.0009.
6
A mathematical approach to study combined effects of toxicants in vitro: evaluation of the Bliss independence criterion and the Loewe additivity model.一种研究体外毒物联合效应的数学方法:Bliss独立性标准和Loewe加和模型的评估
Toxicol In Vitro. 2007 Aug;21(5):759-69. doi: 10.1016/j.tiv.2007.03.003. Epub 2007 Mar 12.
7
Fitting models for the joint action of two drugs using SAS.使用SAS拟合两种药物联合作用的模型。
Pharm Stat. 2008 Oct-Dec;7(4):272-84. doi: 10.1002/pst.312.
8
Additivity versus synergy: a theoretical analysis of implications for anesthetic mechanisms.相加作用与协同作用:对麻醉机制影响的理论分析
Anesth Analg. 2008 Aug;107(2):507-24. doi: 10.1213/ane.0b013e31817b7140.
9
An overview of drug combination analysis with isobolograms.用等效线图进行药物联合分析概述。
J Pharmacol Exp Ther. 2006 Oct;319(1):1-7. doi: 10.1124/jpet.106.104117. Epub 2006 May 2.
10
A simple test for synergy for a small number of combinations.用于少量组合的协同作用的简单测试。
Stat Med. 2013 Dec 20;32(29):5145-55. doi: 10.1002/sim.5905. Epub 2013 Aug 1.

引用本文的文献

1
The synthetic lethal interaction between CDS1 and CDS2 is a vulnerability in uveal melanoma and across multiple tumor types.CDS1和CDS2之间的合成致死相互作用是葡萄膜黑色素瘤以及多种肿瘤类型中的一个脆弱点。
Nat Genet. 2025 Jul 4. doi: 10.1038/s41588-025-02222-1.
2
A Combination of 5-(3',4'-Dihydroxyphenyl)-γ-Valerolactone and Curcumin Synergistically Reduces Neuroinflammation in Cortical Microglia by Targeting the NLRP3 Inflammasome and the NOX2/Nrf2 Signaling Pathway.5-(3',4'-二羟基苯基)-γ-戊内酯与姜黄素联合通过靶向NLRP3炎性小体和NOX2/Nrf2信号通路协同减轻皮质小胶质细胞中的神经炎症。
Nutrients. 2025 Apr 10;17(8):1316. doi: 10.3390/nu17081316.
3
Retinal Protection of New Nutraceutical Formulation.
新型营养制剂的视网膜保护作用
Pharmaceutics. 2025 Jan 7;17(1):73. doi: 10.3390/pharmaceutics17010073.
4
State-of-the-Art Review on Botanical Hybrid Preparations in Phytomedicine and Phytotherapy Research: Background and Perspectives.植物医学与植物疗法研究中植物杂交制剂的最新综述:背景与展望
Pharmaceuticals (Basel). 2024 Apr 10;17(4):483. doi: 10.3390/ph17040483.
5
Revisiting the Checkerboard to Inform Development of β-Lactam/β-Lactamase Inhibitor Combinations.重温棋盘法以指导β-内酰胺/β-内酰胺酶抑制剂联合制剂的研发
Antibiotics (Basel). 2024 Apr 7;13(4):337. doi: 10.3390/antibiotics13040337.
6
Tretinoin Enhances the Effects of Chemotherapy in Juvenile Myelomonocytic Leukemia Using an Ex Vivo Drug Sensitivity Assay.维 A 酸乳膏通过体外药敏试验增强青少年粒单核细胞白血病的化疗效果。
JCO Precis Oncol. 2023 Sep;7:e2300302. doi: 10.1200/PO.23.00302.
7
Challenges of bacteriophages application in controlling bacterial plant diseases and how to overcome them.噬菌体在控制植物细菌病害中的应用挑战及如何克服这些挑战。
J Genet Eng Biotechnol. 2023 Oct 10;21(1):98. doi: 10.1186/s43141-023-00549-y.
8
Constitutively Synergistic Multiagent Drug Formulations Targeting MERTK, FLT3, and BCL-2 for Treatment of AML.针对 AML 的 MERTK、FLT3 和 BCL-2 的组成型协同多药制剂。
Pharm Res. 2023 Sep;40(9):2133-2146. doi: 10.1007/s11095-023-03596-9. Epub 2023 Sep 13.
9
Screening of predicted synergistic multi-target therapies in glioblastoma identifies new treatment strategies.胶质母细胞瘤中预测性协同多靶点治疗的筛选确定了新的治疗策略。
Neurooncol Adv. 2023 Jun 13;5(1):vdad073. doi: 10.1093/noajnl/vdad073. eCollection 2023 Jan-Dec.
10
Latent variable indirect response modeling of clinical efficacy endpoints with combination therapy: application to guselkumab and golimumab in patients with ulcerative colitis.联合治疗临床疗效终点的潜在变量间接反应建模:在溃疡性结肠炎患者中应用古塞库单抗和戈利木单抗
J Pharmacokinet Pharmacodyn. 2023 Apr;50(2):133-144. doi: 10.1007/s10928-022-09841-9. Epub 2023 Jan 17.